Ambady, Prakash
Wu, Yingjen Jeffrey
Kersch, Cymon N.
Walker, Joshua M.
Holland, Samantha
Muldoon, Leslie L.
Neuwelt, Edward A.
Funding for this research was provided by:
Foundation for the National Institutes of Health (CA137488, CA199111)
Walter S. and Lucienne Driskill Foundation
Veterans Administration Merit Review Grant
Article History
Received: 14 July 2020
Revised: 25 January 2021
Accepted: 16 March 2021
First Online: 14 April 2021
Compliance with ethical standards
:
: All morpholino oligonucleotides used were synthesized as per authors’ specifications and purchased, except the AMON sequences that were provided free of cost by Gene Tools, LLC, (Philomath, OR, USA). The US patent application (#16/522,381) entitled “morpholino oligonucleotides useful in cancer treatment” was issued to authors PA, YJW and EAN by the US patent office. Other authors have no financial interests or a conflict of interest with the results reported in this manuscript.